Group 1 - The third meeting of the third supervisory board of Guangdong Guangkang Biochemical Technology Co., Ltd. was held on July 11, 2025, with all three supervisors present [1][2] - The supervisory board approved the decision to continue using part of the idle raised funds for cash management, stating that the decision-making process complies with relevant laws and regulations and is beneficial for increasing company revenue and improving fund utilization efficiency [1][2] - The voting results for the decision were unanimous, with 3 votes in favor, 0 against, and 0 abstentions [2] Group 2 - The meeting was convened and chaired by Mr. Yu Kewei, the chairman of the supervisory board, and the company secretary attended the meeting [1] - The meeting's notice was sent to all supervisors via email and instant messaging on July 8, 2025 [1] - The decision to use idle funds for cash management does not harm the interests of the company or all shareholders [1]
广康生化: 第三届监事会第十八次会议决议公告